|
|
|
51-200 employees
View all
|
|
Biotechnology
|
|
Suite 550,Emeryville,California,US
|
|
Kyverna is a cell therapy company engineering and developing a new class of curative living medicines for inflammatory and autoimmune diseases. Using its SmarTcell™ approach which includes synReg-T cell and synNotch CAR-T technology platforms, Kyverna reprograms T cells to target and selectively suppress or eliminate autoreactive immune cells. The company’s goal is to develop therapies that are selective, potent and durable to tame autoimmunity.
synNotch is a trademark of Gilead/Kite.
|
Kyverna Therapeutics Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
75.00%
|
The widely used Kyverna Therapeutics email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.
To contact Kyverna Therapeutics customer service number in your country click here to find.
Dominic Borie is the CEO of Kyverna Therapeutics.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.